Ata uhi

Prevention and treatment of Clostridium difficile associated diarrhea by reconstitution of the microbiota

This review summarizes the latest advances in treating and preventing Clostridium difficile infection (CDI), the most common infectious disease cause of nosocomial diarrhea in adults in developed countries. As customary antibiotic therapies against C. difficile, metronidazole and vancomycin, are bro...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Noa Eliakim -Raz (Author), Jihad Bishara (Author)
Hōputu:	Pukapuka
I whakaputaina:	Taylor & Francis Group, 2019-06-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Clostridium difficile associated diarrhea - 'suspect, inspect, treat, and prevent'
mā: Shivani Tyagi, me ētahi atu.
I whakaputaina: (2014)

Clostridium difficile-associated diarrhea in dialysis patients
mā: Sook Eui Oh, me ētahi atu.
I whakaputaina: (2013)

Lactobacillus sp as a Probiotic for the Prevention of Clostridium difficile Associated Diarrhea
mā: Ulfa Nur Rohmah, me ētahi atu.
I whakaputaina: (2020)

Prevalence of Clostridium Difficile- Associated Diarrhea in Hospitalized Patients with Nosocomial Diarrhea
mā: N Sadeghifard, me ētahi atu.
I whakaputaina: (2005)

Prevalence of Clostridium Difficile- Associated Diarrhea in Hospitalized Patients with Nosocomial Diarrhea
mā: N Sadeghifard, me ētahi atu.
I whakaputaina: (2005)

Cost analysis of hospitalized Clostridium difficile-associated diarrhea (CDAD)
mā: Hübner, Claudia, me ētahi atu.
I whakaputaina: (2015)

Clostridium difficile in patients with nosocomial diarrhea, Northwest of Iran
mā: Yalda Hematyar, me ētahi atu.
I whakaputaina: (2020)

Fidaxomicin: A new fight against clostridium difficile-associated diarrhea
mā: Dick B. S. Brashier, me ētahi atu.
I whakaputaina: (2014)

Fidaxomicin: A new fight against clostridium difficile-associated diarrhea
mā: Dick B. S. Brashier, me ētahi atu.
I whakaputaina: (2014)

Double-edged sword: threat or not GAS after Clostridium Difficile associated diarrhea
mā: I. Muradyan, me ētahi atu.
I whakaputaina: (2020)

Is Fecal Leukocyte Test a good predictor of <it>Clostridium difficile </it>associated diarrhea?
mā: Sheth Ankur, me ētahi atu.
I whakaputaina: (2006)

Colonization Resistance of the Gut Microbiota against Clostridium difficile
mā: Ana Elena Pérez-Cobas, me ētahi atu.
I whakaputaina: (2015)

Clostridium difficile outbreaks: prevention and treatment strategies
mā: Martinez FJ, me ētahi atu.
I whakaputaina: (2012)

Study of Nosocomial Clostridium Difficile Diarrhea by Culture and Tissue Culture Methods
mā: MH Salari, me ētahi atu.
I whakaputaina: (2007)

Study of Nosocomial Clostridium Difficile Diarrhea by Culture and Tissue Culture Methods
mā: MH Salari, me ētahi atu.
I whakaputaina: (2007)

Case-control Analysis of Clostridium difficile-Associated Diarrhea on a Gynecologic Oncology Service
mā: Steven E. Waggoner, me ētahi atu.
I whakaputaina: (1994)

Clostridium difficile
mā: Emily Macnaughton
I whakaputaina: (2014)

Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection
mā: Caroline Vincent, me ētahi atu.
I whakaputaina: (2015)

Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond
mā: Thomas J. Borody, me ētahi atu.
I whakaputaina: (2015)

Risk Factors for Primary Clostridium difficile Infection; Results From the Observational Study of Risk Factors for Clostridium difficile Infection in Hospitalized Patients With Infective Diarrhea (ORCHID)
mā: Kerrie Davies, me ētahi atu.
I whakaputaina: (2020)

Clostridium difficile infection
mā: Stephen A. Geller, me ētahi atu.
I whakaputaina: (2014)

Clostridium Difficile A Comprehensive Overview
I whakaputaina: (2017)

Distribution and risk factor analysis for Clostridium difficile‐associated diarrhea among hospitalized children over one year of age
mā: Chunna Zhao, me ētahi atu.
I whakaputaina: (2020)

New advances in the treatment of Clostridium difficile infection (CDI)
mā: Dennis D Hedge, me ētahi atu.
I whakaputaina: (2008)

Enfermedad asociada a Clostridium difficile: prevalencia y diagnóstico por laboratorio Clostridium difficile associated disease: Prevalence and diagnostic laboratory
mā: Jhon Walter Zea, me ētahi atu.
I whakaputaina: (2012)

Detection of Clostridium difﬁcile associated diarrhea in disease based on Polymerase chain reaction and bacterial culture And toxin A, B frequency
mā: mohsen zargar, me ētahi atu.
I whakaputaina: (2019)

Clostridium Difficile Infection in the Nephrology Ward
mā: Sylwia Dudzicz, me ētahi atu.
I whakaputaina: (2017)

Clostridium difficile: ¿un patógeno reemergente?
mā: Gabriela Echániz Avilés
I whakaputaina: (2006)

Antimicrobials for treating Clostridium difficile infections
mā: K. Sridharan
I whakaputaina: (2020)

High Clostridium difficile Infection among HIV-Infected Children with Diarrhea in a Tertiary Hospital in Mwanza, Tanzania
mā: Mwanaisha Seugendo, me ētahi atu.
I whakaputaina: (2020)

Clostridium difficile on YouTube: A need for greater focus on prevention
mā: Corey H. Basch, me ētahi atu.
I whakaputaina: (2018)

In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection
mā: Christine Roder, me ētahi atu.
I whakaputaina: (2020)

Genomic Delineation of Zoonotic Origins of Clostridium difficile
mā: Daniel R. Knight, me ētahi atu.
I whakaputaina: (2019)

Infection Clostridium difficile as increasing epidemiological issue
mā: Maciej Rutkowski, me ētahi atu.
I whakaputaina: (2017)

Infection Clostridium difficile as increasing epidemiological issue
mā: Maciej Rutkowski, me ētahi atu.
I whakaputaina: (2017)

The Antimicrobial Stewardship Approach to Combating Clostridium Difficile
mā: Eric Wenzler, me ētahi atu.
I whakaputaina: (2015)

Recurrent Clostridium difficile infection treated with bezlotoxumab
mā: Beatriz Palenzuela Afonso, me ētahi atu.
I whakaputaina: (2023)

Clostridium difficile Infection: Incidence in an Australian Setting
mā: Brett G. Mitchell, PhD
I whakaputaina: (2014)

Hemolytic uremic syndrome and Clostridium difficile colitis
mā: Maryam Keshtkar-Jahromi, me ētahi atu.
I whakaputaina: (2012)

A prediction model for Clostridium difficile recurrence
mā: Francis D. LaBarbera, me ētahi atu.
I whakaputaina: (2015)